3 Biotech Stocks With Huge Catalysts in June

Biotech investors better buckle up for a wild ride this month. Some of the industry's biggest players are waiting for clinical trial results and decisions from the FDA that could send their stock prices rocketing higher overnight or stomp them into the dirt.

Here's why shares of Biogen (NASDAQ: BIIB), Vertex Pharmaceuticals (NASDAQ: VRTX), and Sage Therapeutics (NASDAQ: SAGE) will be extra jumpy this month. 

Image source: Getty Images.

Continue reading

Source Fool.com